Evidence map›Paper›PMID 30496303›Full record

ArticlePLoS pathogens2018

Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.

Matthew D J Dicks, Gilberto Betancor, Jose M Jimenez-Guardeño, Lucie Pessel-Vivares, Luis Apolonia, Caroline Goujon, Michael H Malim

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. MX2 Mediates Collapse of the HIV-1 Capsid.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Cyclophilin A Regulates Tripartite Motif 5 Alpha Restriction of HIV-1.International journal of molecular sciences · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Capsid-host interactions for HIV-1 ingress.Microbiology and molecular biology reviews : MMBR · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Matthew D J DicksDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0003-1909-7095
Gilberto BetancorDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0003-0548-7690
Jose M Jimenez-GuardeñoDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-1726-8033
Lucie Pessel-VivaresDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-8960-2408
Luis ApoloniaDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-9451-6117
Caroline GoujonDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0001-8571-1108
Michael H MalimDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-7699-2064
King's College London · GB

Funding

Project 9P50GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SHARPLESS, KARL BARRY · 2012 to 2016
$20.0M
A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance AbuseR01DA033773 · NIDA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLINSKY, STEVEN M · 2012 to 2016
$4.6M
Medical Research Council G1000196NIDA NIH HHS R01 DA033773NIGMS NIH HHS P50 GM103368Wellcome TrustWellcome Trust 106223/Z/14/Z
6 · The paper itself

Abstract

Human myxovirus resistance 2 (MX2/MXB) is an interferon-induced post-entry inhibitor of human immunodeficiency virus type-1 (HIV-1) infection. While the precise mechanism of viral inhibition remains unclear, MX2 is localized to the nuclear envelope, and blocks the nuclear import of viral cDNAs. The amino-terminus of MX2 (N-MX2) is essential for anti-viral function, and mutation of a triple arginine motif at residues 11 to 13 abrogates anti-HIV-1 activity. In this study, we sought to investigate the role of N-MX2 in anti-viral activity by identifying functionally relevant host-encoded interaction partners through yeast-two-hybrid screening. Remarkably, five out of seven primary candidate interactors were nucleoporins or nucleoporin-like proteins, though none of these candidates were identified when screening with a mutant RRR11-13A N-MX2 fragment. Interactions were confirmed by co-immunoprecipitation, and RNA silencing experiments in cell lines and primary CD4+ T cells demonstrated that multiple components of the nuclear pore complex and nuclear import machinery can impact MX2 anti-viral activity. In particular, the phenylalanine-glycine (FG) repeat containing cytoplasmic filament nucleoporin NUP214, and transport receptor transportin-1 (TNPO1) were consistently required for full MX2, and interferon-mediated, anti-viral function. Both proteins were shown to interact with the triple arginine motif, and confocal fluorescence microscopy revealed that their simultaneous depletion resulted in diminished MX2 accumulation at the nuclear envelope. We therefore propose a model whereby multiple components of the nuclear import machinery and nuclear pore complex help position MX2 at the nuclear envelope to promote MX2-mediated restriction of HIV-1.

Indexed as

Active Transport, Cell NucleusAntiviral Agentsbeta KaryopherinsHEK293 CellsHeLa CellsHIV-1HIV InfectionsHost-Pathogen InteractionsHumansInterferonsMyxovirus Resistance ProteinsNuclear EnvelopeNuclear PoreNuclear Pore Complex ProteinsVirus ReplicationAntiviral Agentsbeta KaryopherinsInterferonsMX2 protein, humanMyxovirus Resistance ProteinsNuclear Pore Complex ProteinsNUP214 protein, humanTNPO1 protein, human

Identifiers

PMID30496303
PMCPMC6264145
OpenAlexW2902374379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.